{
    "SPADE_UN_13441": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13441",
            "Peptide Name": "GHaR9W (variant of temporin-GHaR)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "FLQRIIGAWGRLL",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "[Ref.33291521] Gram-positive bacteria:S. aureus(MIC / MBC = 3.1μM / 6.2μM), B. subtilis(MIC / MBC = 12.5μM / 50μM), S. mutans(MIC / MBC = 6.2μM /  6.2μM), MRSA(MIC / MBC = 6.2μM / 12.5μM), MRSA-1(MIC / MBC = 6.2μM / 12.5μM), MRSA-2(MIC / MBC = 6.2μM / 12.5μM), MRSA-3(MIC / MBC = 6.2μM / 12.5μM)Gram-negative bacteria:E. coli(MIC / MBC = 12.5μM / 12.5μM),  D31(MIC /MBC = 12.5μM / 50μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC = 25μM / 50μM)Fungi:C. albicans(MIC / MBC = 25μM / 25μM)",
            "Hemolytic Activity": "[Ref.33291521]HL50 = 90μM against human red blood cells (hRBCs)",
            "Cytotoxicity": "[Ref.33291521]GHaR6R induced a cell viability of 74%, 63% and 60% to human oral epithelial cells at 3.1μM, 6.2μM and 12.5μM.",
            "Binding Target": "Cell membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C74H119N21O15",
            "Mass": 1542.87,
            "PI": 12.0,
            "Net Charge": 2,
            "Hydrophobicity": 0.83,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Comments": "GHaR6R not only exerted antimicrobial activity by destroying cell membranes of planktonic bacteria, but also exhibited anti-biofilm activity. The low-toxicity peptides of GHaR6R is expected to become promising antimicrobial candidate to develop anti-caries agents.",
            "Literature": [
                {
                    "Title": "Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis",
                    "Pubmed ID": "33291521",
                    "Reference": "Molecules. 2020 Dec 4;25(23)5724. doi 10.3390/molecules25235724.",
                    "Author": "Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33291521"
                }
            ],
            "Frequent Amino Acids": "LGI",
            "Absent Amino Acids": "CDEHKMNOPSTUVY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 4,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_25515",
                    "Similarity": 1.0,
                    "Sequence": "GRLLKFIKKAQRKFVEKFAK"
                },
                {
                    "SPADE_ID": "SPADE_UN_13436",
                    "Similarity": 0.8461538461538461,
                    "Sequence": "FLQRIIGALGRLF"
                },
                {
                    "SPADE_ID": "SPADE_UN_13440",
                    "Similarity": 0.8461538461538461,
                    "Sequence": "FLQRIIGARGRLF"
                }
            ]
        }
    }
}